OPPORTUNITIES FOR INTEGRATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICOKINETICS IN RATIONAL DRUG DEVELOPMENT

被引：30

作者：

PECK, CC

BARR, WH

BENET, LZ

COLLINS, J

DESJARDINS, RE

FURST, DE

HARTER, JG

LEVY, G

LUDDEN, T

RODMAN, JH

SANATHANAN, L

SCHENTAG, JJ

SHAH, VP

SHEINER, LB

SKELLY, JP

STANSKI, DR

TEMPLE, RJ

VISWANATHAN, CT

WEISSINGER, J

YACOBI, A

机构：

[1] US FDA, CTR DRUG EVALUAT & RES, ROCKVILLE, MD 20857 USA

[2] VIRGINIA COMMONWEALTH UNIV, SCH PHARM, RICHMOND, VA 23298 USA

[3] UNIV CALIF SAN FRANCISCO, SCH MED, SAN FRANCISCO, CA 94143 USA

[4] AMER CYANAMID CO, PEARL RIVER, NY 10965 USA

[5] CIBA GEIGY PHARMACEUT CORP, SUMMIT, NJ 07901 USA

[6] SUNY BUFFALO, BUFFALO, NY 14260 USA

[7] ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38105 USA

[8] SUNY BUFFALO, MILLARD FILLMORE HOSP, CLIN PHARMACOKINET LAB, BUFFALO, NY 14209 USA

[9] UNIV CALIF SAN FRANCISCO, MED CTR, SAN FRANCISCO, CA 94143 USA

[10] VET ADM MED CTR, DEPT ANESTHESIA, PALO ALTO, CA 94304 USA

来源：

关键词：

D O I：

10.1002/jps.2600810630

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：605 / 610

页数：6